Scott is a Director and a founder of Cofactor Group. His 20+ years of healthcare experience includes senior management positions in the research, diagnostic and supply chain industries, and strategic consulting for emerging and top-tier pharmaceutical manufacturers.
While at Cofactor Group, his key areas of focus have been development of Commercial and Medical launch strategies across a range of therapeutic areas including oncology, autoimmune disorders, cardiovascular and GI. Prior to founding Cofactor Group, he led the launch and rapid growth of innovative technologies in the DNA analysis and immuno-separation markets. He also managed a Corporate Development team that secured partnerships for technology access and market expansion.
He holds BS degrees in Molecular Biology and Biochemistry from the University of Wisconsin-Madison and an MBA from the Darden School of Business at the University of Virginia.
Cofactor partnered with a biotechnology organization to inform critical investment decisions about a potential treatment for SARS-CoV-2 infection.
Co-commercialization or co-promotion agreements have become the new norm in the life sciences industry, and all have one thing in common - they are challenging. Cofactor provides specific alliance expertise, capabilities, and tools that can help your alliance work more effectively.